Twitter

Link your Twitter Account to Market Wire News


When you linking your Twitter Account Market Wire News Trending Stocks news and your Portfolio Stocks News will automatically tweet from your Twitter account.


Be alerted of any news about your stocks and see what other stocks are trending.

home / news releases / SNDX - Syndax Pharmaceuticals Inc. (SNDX) CEO Michael Metzger on Q4 2021 Results - Earnings Call Transcript

SNDX - Syndax Pharmaceuticals Inc. (SNDX) CEO Michael Metzger on Q4 2021 Results - Earnings Call Transcript

Syndax Pharmaceuticals Inc.
Syndax Pharmaceuticals, Inc. (SNDX) Q4 2021 Earnings Conference Call March 1, 2022 4:30 PM ET Company Participants Maghan Meyers - Vice President, Argot Partners Michael Metzger - Chief Executive Officer Alexander Nolte - Chief Accounting Officer Anjali Ganguli - Chief Business Officer Briggs Morrison - President and Head of Research and Development Conference Call Participants Phil Nadeau - Cowen Inc. Robert Hazlett - BTIG, LLC Ashiq Mubarack - Citigroup Inc. Justin Walsh - B. Riley Securities, Inc. Joel Beatty - Robert W. Baird & Co. Peter Lawson - Barclays PLC Presentation Operator Good day, everyone, and welcome to the Syndax Fourth Quarter 2021 Earnings Conference Call. Today’s call is being recorded. At this time, I would like to turn the call over to Maghan Meyers of Argot Partners. Please begin. Maghan Meyers Thank you, operator. Welcome and thank you to those of you joining us on the line and the

For further details see:

Syndax Pharmaceuticals, Inc. (SNDX) CEO Michael Metzger on Q4 2021 Results - Earnings Call Transcript
Stock Information
Company Name: Syndax Pharmaceuticals Inc.
Stock Symbol: SNDX
Market: NASDAQ
Website: syndax.com
Menu
SNDX SNDX Quote SNDX Short SNDX News SNDX Articles SNDX Message Board
Get SNDX Alerts

News, Short Squeeze, Breakout and More Instantly...